However, in females with MS, cells expressing AR protein appeared to be increased in active lesions and perilesional areas of chronic active lesions, where there is potential to remyelinate, and fewer in the center of chronic active lesions and normal appearing white matter (Supplementary Fig. 1c–f). The gene discussed is AR; the disease is myeloid sarcoma.